ST103
|
miRNAs up-regulated
|
Mucin type O-Glycan biosynthesis
|
1.4E-4
|
0.01
|
GALNT3; GALNT4; GALNT9; POC1B-GALNT4;
|
GABA receptor activation
|
1.0E-4
|
0.02
|
GABRA1; GABRB2; GNG10; GNG5; KCNJ2;
|
Regulation of gene expression in early pancreatic precursor cells
|
0.001
|
0.06
|
ONECUT1; ONECUT3;
|
miRNAs down-regulated
|
Integrin signaling pathway
|
0.004
|
0.10
|
ACTN1; ACTN2; BCR; CAV1; FYN; ITGA1; MAPK8; PXN; SOS1; TNS1; VCL;
|
Sodium/Calcium exchangers
|
0.003
|
0.11
|
SLC24A1; SLC24A2; SLC24A3; SLC24A4; SLC8A1; SLC8A2; SLC8A3;
|
Reduction of cytosolic Ca++ levels
|
0.004
|
0.11
|
ATP2A2; ATP2B1; ATP2B2; ATP2B3; ATP2B4; SLC8A1; SLC8A2; SLC8A3;
|
ST12
|
miRNAs up-regulated
|
Activation of G protein gated Potassium channels
|
2.3E-4
|
0.04
|
GNB3; GNG10; GNG2; GNG5; KCNJ6;
|
G protein gated Potassium channels
|
2.3E-4
|
0.04
|
GNB3; GNG10; GNG2; GNG5; KCNJ6;
|
Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits
|
2.3E-4
|
0.04
|
GNB3; GNG10; GNG2; GNG5; KCNJ6;
|
miRNAs down-regulated
|
IL4-mediated signaling events
|
5.1E-4
|
0.15
|
BCL2L1; CCL11; CCL26; FCER2; IL10; IRF4; IRS2; SOCS1; SOCS5; STAT6;
|
Intrinsic Pathway for Apoptosis
|
3.6E-4
|
0.16
|
BAK1; BAX; BCL2L1; BMF; CASP7; TFDP1; YWHAB; YWHAG;
|
Role of parkin in ubiquitin-proteasomal pathway
|
3.1E-4
|
0.28
|
PARK2; UBE2E2; UBE2G1; UBE2L3;
|